AIM
ARK Investment Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,214,863
| Closed | -$42.5M | – | 225 |
|
|
2022
Q4 | $42.5M | Sell |
4,214,863
-7,440,970
| -64% | -$75.1M | 0.37% | 42 |
|
|
2022
Q3 | $261M | Buy |
11,655,833
+182,178
| +2% | +$4.08M | 1.82% | 19 |
|
|
2022
Q2 | $265M | Buy |
11,473,655
+485,473
| +4% | +$11.2M | 1.57% | 20 |
|
|
2022
Q1 | $426M | Buy |
10,988,182
+676,015
| +7% | +$26.2M | 1.78% | 17 |
|
|
2021
Q4 | $603M | Sell |
10,312,167
-590,091
| -5% | -$34.5M | 1.82% | 18 |
|
|
2021
Q3 | $646M | Buy |
10,902,258
+3,419,156
| +46% | +$203M | 1.55% | 20 |
|
|
2021
Q2 | $649M | Buy |
7,483,102
+928,556
| +14% | +$80.6M | 1.21% | 26 |
|
|
2021
Q1 | $540M | Buy |
6,554,546
+3,652,846
| +126% | +$301M | 1.07% | 28 |
|
|
2020
Q4 | $264M | Buy |
2,901,700
+1,461,730
| +102% | +$133M | 0.7% | 41 |
|
|
2020
Q3 | $57.6M | Buy |
1,439,970
+420,140
| +41% | +$16.8M | 0.34% | 53 |
|
|
2020
Q2 | $35M | Buy |
1,019,830
+464,748
| +84% | +$15.9M | 0.38% | 45 |
|
|
2020
Q1 | $12.3M | Buy |
555,082
+123,954
| +29% | +$2.75M | 0.31% | 53 |
|
|
2019
Q4 | $8.44M | Buy |
431,128
+92,089
| +27% | +$1.8M | 0.21% | 60 |
|
|
2019
Q3 | $5.27M | Buy |
339,039
+116,975
| +53% | +$1.82M | 0.11% | 71 |
|
|
2019
Q2 | $4.51M | Buy |
+222,064
| New | +$4.51M | 0.11% | 75 |
|